The Johnson & Johnson COVID-19 single-dose vaccine has been reported to be compatible with standard vaccine storage and distribution channels with ease of delivery to remote areas and can be transported using the same cold chain technologies used to transport treatments for cancer, immunological disorders and other medicines.
